Aduro BioTech Revenue and Competitors

Location

$177.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aduro BioTech's estimated annual revenue is currently $15M per year.(i)
  • 0
  • Aduro BioTech's total funding is $177.7M.

Employee Data

    00

Aduro BioTech's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Aduro BioTech?

Aduro BioTech is a privately held, clinical-stage biotechnology company located in the Berkeley, CA. Our initial focus is to develop immunotherapies for infectious diseases and cancer. Aduro BioTech is already developing therapeutic vaccines for treating cancers that over-express Mesothelin and for treating people infected with the hepatitis C virus (HCV).

keywords:N/A

$177.7M

Total Funding

N/A

Number of Employees

$15M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aduro BioTech News

2022-04-20 - Emerging Cancer Vaccines Market Size And Forecast | CSL ...

CSL Limited, ADURO BIOTECH INC., Astellas Pharma Inc., Merck & Co. Sanofi, Bristol-Myers Squibb Company, GlaxoSmithKline Plc., Dendreon,...

2022-04-20 - Global Cancer Vaccines Market Analysis Report 2022-2030 ...

... 2022-2030 Featuring Major Players - GSK, Merck, Aduro Biotech, Astrazeneca Plc., Dendreon, Astellas Pharma Inc., Sanofi Pasteur, Sanpower Group and CSL.

2022-04-17 - Nano Biotechnology Market Outlook, Demand Analysis and ...

Nano Biotechnology Market Outlook, Demand Analysis and Forecast from 2022-2028 | Aduro Biotech, Biosante Phosphate Pharmaceuticals Inc, Calando...

2015-01-05 - Aduro Biotech Closes $51.4M Series D Financing

Aduro Biotech, Inc., a Berkeley, California-based clinical-stage immuno-oncology company, closed a $51.4m Series D financing. Backers included new investors OrbiMed, Janus Capital Management LLC, funds managed by Franklin Advisers, Inc., Jennison Associates LLC (on behalf of certain clients), F ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2147.5M0N/AN/A
#2
$10M0N/A$6M
#3
$7.1M0N/A$7.2M
#4
$0.1M10%N/A
#5
$0.1M1-80%N/A